![cover image](https://wikiwandv2-19431.kxcdn.com/_next/image?url=https://upload.wikimedia.org/wikipedia/commons/thumb/b/b2/Ensaculin.svg/640px-Ensaculin.svg.png&w=640&q=50)
Ensaculin
Chemical compound / From Wikipedia, the free encyclopedia
Ensaculin (KA-672) is a drug from the coumarin family, which has been researched as a potential treatment for dementia. It acts on a number of receptor systems, being both a weak NMDA antagonist and a 5HT1A agonist.[1][2] Animal studies have shown promising nootropic effects,[3][4] although efficacy in humans has yet to be proven. It was well tolerated in human trials, with the main side effect being orthostatic hypotension (low blood pressure).[5]
Quick Facts Clinical data, ATC code ...
![]() | |
Clinical data | |
---|---|
ATC code |
|
Pharmacokinetic data | |
Elimination half-life | 13.7 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C26H32N2O5 |
Molar mass | 452.551 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Close